Five Years of Renal Transplantations in Montenegro: Results and Challenges

Abstract First renal transplantation in Montenegro was performed on September 25th, 2012. Since then, 32 transplantations have been performed. Only one was from deceased donor, the remaining were from living donors. 40.4% of all patients with end-stage renal disease currently live with the functioning renal allograft (190 patients on dialysis, 129 transplanted patients). There are 32 patients on the waiting list. Further efforts will be focused on development of the deceased donor program and introduction of the AB0 incompatible renal transplantations.

Download Full-text

Acute coronary syndromes in patients with end stage renal disease resulting from diabetes after renal transplantation compared with patients on the renal transplant waiting list

American Journal of Kidney Diseases ◽

10.1016/s0272-6386(01)80181-5 ◽

2001 ◽

Vol 37 (4) ◽

pp. A19

Author(s):

Iman O. Hypolite ◽

Jay Bucci ◽

Christina M. Yuan ◽

Allan Taylor ◽

Paul Hshieh ◽

...

Keyword(s):

Renal Transplantation ◽

Renal Transplant ◽

Renal Disease ◽

End Stage Renal Disease ◽

Acute Coronary Syndromes ◽

Waiting List ◽

Coronary Syndromes ◽

Stage Renal Disease ◽

End Stage

Download Full-text

Evaluation of long-term outcomes of deceased donor renal transplantation in patients with end-stage renal disease

Journal of Nephropharmacology ◽

10.15171/npj.2019.29 ◽

2019 ◽

Vol 8 (2) ◽

pp. 29-29

Author(s):

Jaiju James Chakola ◽

Varun Mamidi ◽

Vamsi Krishna Makkena ◽

Jayakumar Matcha ◽

Ramprasad Elumalai

Keyword(s):

Renal Transplantation ◽

Renal Disease ◽

End Stage Renal Disease ◽

Deceased Donor ◽

Long Term Outcomes ◽

Stage Renal Disease ◽

End Stage

Download Full-text

Factors influencing disease recurrence and graft survival in patients who developed end stage renal disease due to focal segmental glomerulosclerosis and underwent renal transplantation

International Surgery ◽

10.9738/intsurg-d-15-00154.1 ◽

2018 ◽

Author(s):

Vural Taner Yilmaz ◽

Huseyin Kocak ◽

Ramazan Cetinkaya ◽

Burak Veli Ulger ◽

Gultekin Suleymanlar

Keyword(s):

Renal Transplantation ◽

Renal Disease ◽

Graft Survival ◽

End Stage Renal Disease ◽

Living Donor ◽

Survival Rates ◽

Deceased Donor ◽

Disease Recurrence ◽

Stage Renal Disease ◽

End Stage

Aim: The aim of our study was to determine the factors effecting disease recurrence and graft survival in patients who developed end stage renal disease (ESRD) due to focal segmental glomerulosclerosis (FSGS) and underwent renal transplantation (Rtx). Methods: A total of 37 patients with FSGS (Female/Male: 10/27) who underwent Rtx in our transplant center between 2001 and 2014 were included in the study. The patients were diagnosed with FSGS by biopsy. Comparative analyses were performed in order to determine the factors effecting disease recurrence and graft survival. Plasmapheresis was performed with 40 ml/kg plasma. The diagnosis of the recurrence of FSGS and the acute rejections were also confirmed by biopsy. Results: Statistical analyses revealed that, recurrence rates were higher in Rtx recipients from deceased donor (deceased donor vs. living donor, 2 (50.0%) vs. 3 (9.1%), p=0.024). However, no correlation was found between recurrence and renal replacement treatment (RRT) methods, duration of RRT, preoperative or postoperative prophilactic plasmapheresis, the presence of preoperative nephrotic proteinuria, donor's or recipient's age or gender, kinship with donor, time interval between development of FSGS and ESRD, or performing native nephrectomy. Graft survival rates were higher in Rtx patients which were transplanted from living donor, first degree relatives and in patients without recurrence. Conclusion: In countries where organ donation is insufficient, living donors can be used with a low risk of recurrence for Rtx candidates with FSGS. Also, grafts from living donors, particularly from first degree relatives, have higher survival rates.

Download Full-text